NASDAQ:EXEL

Exelixis Stock Insider Trading

etoro logo Buy EXEL
*Your capital is at risk
$51.60
+3.06 (+6.30%)
At Close: Jun 03, 2026

Exelixis Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at -51.01. In total, the insiders bought 3.36M and sold 3.08M EXEL shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
-51.01
Buy 3.36M shares
Sell 3.08M shares
45% Buy Activity
Moderate Positive Correlation
Sell Signal High Confidence
Feb 18, 2026

Analysis Breakdown:

  • Strongly supported by a very low Insider Power Score of -51.01.
  • Partially supported by a positive historical correlation.
  • Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date Type Person Role Amount
Jan 15, 2026
Sell
Common Stock
F-InKind
Morrissey Michael
President And CEO
CEO / President 139 524
Value: $6.31M
Jan 15, 2026
Buy
Common Stock
A-Award
Morrissey Michael
President And CEO
CEO / President 548 073
Value: $24.9M
Jan 15, 2026
Buy
Common Stock
A-Award
Aftab Dana
EVP, Research And Development
Officer 119 578
Value: $5.43M
Jan 15, 2026
Buy
Common Stock
A-Award
Haley Patrick J.
EVP, Commercial
Officer 139 508
Value: $6.34M
Jan 15, 2026
Buy
Common Stock
A-Award
Senner Christopher J.
EVP And CFO
C-Suite Officer 149 474
Value: $6.79M
Dec 03, 2025
Buy
Common Stock
A-Award
Hefti Brenda
SVP And General Counsel
Officer 30 170
Value: $1.33M
Nov 25, 2025
Buy
Common Stock
P-Purchase
Johnson David Edward
Director
Director 27 532
Value: $1.19M
Nov 21, 2025
Sell
Common Stock
S-Sale
Haley Patrick J.
EVP, Commercial
Officer 28 043
Value: $1.19M
Nov 21, 2025
Sell
Common Stock
G-Gift
Aftab Dana
EVP, Research And Development
Officer 24 000
Value: $0
Nov 20, 2025
Sell
Common Stock
S-Sale
Haley Patrick J.
EVP, Commercial
Officer 10 648
Value: $444.8K
Nov 20, 2025
Sell
Common Stock
S-Sale
Haley Patrick J.
EVP, Commercial
Officer 10 000
Value: $421.1K
Nov 20, 2025
Sell
Common Stock
S-Sale
Haley Patrick J.
EVP, Commercial
Officer 23 539
Value: $987.0K
Nov 17, 2025
Sell
Common Stock
G-Gift
Oliver Bob
Director
Director 1 044
Value: $0
Nov 12, 2025
Sell
Common Stock
G-Gift
Morrissey Michael
President And CEO
CEO / President 101 548
Value: $0
Nov 12, 2025
Sell
Common Stock
G-Gift
Morrissey Michael
President And CEO
CEO / President 80 000
Value: $0
Nov 12, 2025
Buy
Common Stock
G-Gift
Morrissey Michael
President And CEO
CEO / President 101 548
Value: $4.43M
Nov 12, 2025
Sell
Common Stock
S-Sale
Papadopoulos Stelios
Director
Director 100 000
Value: $4.36M
Nov 11, 2025
Buy
Option (right to buy)
M-Exempt
Beckerle Mary C
Director
Director 5 784
Value: $134.4K
Nov 11, 2025
Sell
Common Stock
S-Sale
Beckerle Mary C
Director
Director 5 784
Value: $243.1K
Nov 11, 2025
Buy
Common Stock
M-Exempt
Beckerle Mary C
Director
Director 5 784
Value: $134.4K
Nov 11, 2025
Sell
Common Stock
G-Gift
Morrissey Michael
President And CEO
CEO / President 160 000
Value: $0
Nov 11, 2025
Sell
Common Stock
S-Sale
Aftab Dana
EVP, Research And Development
Officer 48 383
Value: $2.06M
Nov 11, 2025
Sell
Common Stock
S-Sale
Beckerle Mary C
Director
Director 18 838
Value: $789.3K
Nov 07, 2025
Buy
Common Stock
Hefti Brenda
SVP And General Counsel
Officer 0
Value: $0
Nov 07, 2025
Buy
Common Stock
Hefti Brenda
SVP And General Counsel
Officer 0
Value: $0

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT EXELIXIS
Exelixis
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ capsules for the treatment of patients with progressive and metastatic medullary thyroid cancer. Its CA...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE